Vaccines for otitis media and other pediatric pneumococcal diseases

Drug Discovery Today: Therapeutic Strategies

Volumn 3, Issue 2, 2006, Pages 121-127

  Malinoski, Frank J ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DIPHTHERIA TOXOID; HAEMOPHILUS INFLUENZAE VACCINE; PNEUMOCOCCUS VACCINE;

ANTIBACTERIAL ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTERIAL MENINGITIS; CELLULAR IMMUNITY; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; HUMAN; INFECTION PREVENTION; NONHUMAN; OTITIS MEDIA; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 33746822944     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2006.06.004     Document Type: Review

References (27)

1. WHO position paper (2003) Wkly. Epidemiol. Rec. 78, 97-120.
2. Barkai G., et al. Community prescribing and resistant Streptococcus pneumoniae. Emerg. Infect. Dis. 11 (2005) 829-837
3. Hava D.L., et al. From nose to lung: the regulation behind Streptococcus pneumoniae virulence factors. Mol. Microbiol. 50 (2003) 1103-1110
4. Smit P., et al. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 238 (1977) 2613-2616
5. Black S., et al. Efficacy, safety and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19 (2000) 187-195
6. Black S.B., et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr. Infect. Dis. J. 21 (2002) 810-815
7. O'Brien K.L., et al. A group-randomized efficacy and safety trial of a seven valent conjugate pneumococcal vaccine against invasive pneumococcal disease among high risk American Indian children. Lancet 362 (2003) 355-361
8. Klugman K.P., et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N. Engl. J. Med. 349 (2003) 1341-1348
9. Madhi S.A., et al. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin. Infect. Dis. 40 (2005) 1511-1518
10. Cutts F.T., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebo-controlled trial. Lancet 365 (2005) 1113-1114
11. Lucero, M.G. et al. (2004) Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst. Rev. 4, CD004977
12. Obaro S., and Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J. Med. Microbiol. 51 (2002) 98-104
13. O'Brien K.L., and Santosham M. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases. Am. J. Epidemiol. 159 (2004) 634-644
14. Whitney C.G., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348 (2003) 1737-1746
15. Fireman B., et al. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr. Infect. Dis. J. 22 (2003) 10-16
16. Eskola J., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344 (2001) 403-409
17. Kilpi T., et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin. Infect. Dis. 37 (2003) 1155-1164
18. Prymula R., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomized double-blind efficacy study. Lancet 367 (2006) 740-748
19. Palmu A.A., et al. The seven-valent pneumococcal conjugate vaccine reduces typanostomy tube placement in children. Pediatr. Infect. Dis. J. 23 (2004) 732-738
20. Straetemans M et al. (2004) Pneumococcal vaccines for preventing otitis media (Review). Cochrane Database of Syst. Rev. 1, CD001480.pub2
21. Casey J.R., and Pichichero M.E. Changes in frequency and pathogens causing acute otitis media in. Pediatr. Infect. Dis. J. 23 (1995-2003) 824-828
22. Block S.L., et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr. Infect. Dis. J. 23 (2004) 829-833
23. McEllistrem M.C., et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis. 40 (2005) 1738-1744
24. Hamel J., et al. Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins. Infect. Immun. 72 (2004) 2659-2670
25. Austrian R. Pneumococcal otitis media and pneumococcal vaccines, a historical perspective. Vaccine 19 (2001) S71-S77
26. Whitney C.G., et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343 (2000) 1917-1924
27. Bogaert D., et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. The Lancet 363 (2004) 1871-1872